A randomised controlled trial of oxytocin 5 IU versus oxytocin 5 IU and 30 IU infusion for the control of blood loss at elective caesarean section: a pilot study
Completed
- Conditions
- Study of blood loss associated with different use of syntocinonPregnancy and Childbirth
- Registration Number
- ISRCTN40302163
- Lead Sponsor
- HS Tayside (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 120
Inclusion Criteria
Pregnant women choosing to have elective caesarean section at term in a healthy low risk pregnancy.
Exclusion Criteria
1. Women who do not understand English
2. Have a pregnancy complicated by thrombocytopenia
3. Coagulopathy or anti-coagulant therapy
4. Are expecting a multiple birth
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcome measure is estimated blood loss at caesarean section.
- Secondary Outcome Measures
Name Time Method 1. Change in haemoglobin and haematocrit<br>2. Need for additional uterotonic agents<br>3. Incidence of major obstetric haemorrhage<br>4. Need for blood transfusion, side effects and length of sat in the labour ward